Dr. CR Thomas is co-author of JNCI article describing novel dose-escalation strategy for SBRT
10/22/15 Portland, Ore.
Dr. CR Thomas is co-author of JNCI article describing novel dose-escalation strategy for SBRT using an isotoxic dose prescription approach. The article titled "Increasing the therapeutic ratio of stereotactic ablative radiotherapy by individualized isotoxic dose prescription" is published in the JNCI 108(2), 2015.
Co-authors include Drs. Jaap Zindler (lead author, MAASTRO, Maastricht University, Stephen Hahn (MD Anderson Cancer Center), Aswin L. Hoffmann & Esther G.C. Troost (Helmholtz Zentrum Dresden-Rossendorg, Germany), & Philippe Lambin (MAASTRO, Maastricht University). This paper was developed from the 16th Flims (ECCO, AAACR) Workshop on Methods in Clinical Cancer Research, Switzerland, held in June 2014.